Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

OBJECTIVES: In 2010, the 13-valent pneumococcal conjugate vaccine (PCV-13) replaced the 7-valent vaccine (introduced in 2006) for vaccination against invasive pneumococcal diseases (IPDs), pneumonia and acute otitis media (AOM) in the UK. Using recent evidence on the impact of PCVs and epidemiologic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Delgleize, Emmanuelle, Leeuwenkamp, Oscar, Theodorou, Eleni, Van de Velde, Nicolas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2016
Gaiak:
Health Economics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5168567/
https://ncbi.nlm.nih.gov/pubmed/27903558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-010776
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak